| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |